J&j Innovative Medicine recalls IMAAVY (nipocalimab-aahu) Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of particulate matter.
- Products
-
- IMAAVY (nipocalimab-aahu) Injection
- Company
- J&j Innovative Medicine
- Where it was sold
-
OH
States: Ohio
- Units affected
- 49 vials
- About this recall
- IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01